Last update:
Medications news
Medications
Diabetes drug shows potential to slow prostate cancer cell growth
An international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of diabetes and cancer: as the researchers show, the protein PPARγ, which is central to the regulation ...
9 hours ago
0
7
How a cholesterol drug may prevent heart attacks
A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people with coronary artery disease—a leading cause of death in the United States.
4 hours ago
0
0
Alzheimer's: Certain combinations of prescription drugs may slow progression of disease, according to mice study
Millions of older adults take five or more prescription drugs every day to manage chronic illnesses. While polypharmacy is often necessary, this practice has also been linked to many negative health outcomes in older adults—including ...
7 hours ago
0
0
Pooled buying can reduce costs of life-saving drugs, but planning is key
Pooling orders for life-saving medicines can help drive down their cost and ensure a steady supply for low- and middle-income countries, though there are trade-offs, according to a new study led by a University of Massachusetts ...
7 hours ago
0
0
Lifesaving opioid addiction meds are rarely started after emergency visits for overdose
Medications proven to effectively treat opioid addiction are rarely given after emergency department visits for overdose, and who gets them varies, sometimes greatly, depending on race, ethnicity or geography, University ...
8 hours ago
0
0
Nearly quarter of people on long-acting opioids develop addiction, study reveals
More than one in five people prescribed extended-release painkillers such as OxyContin developed an addiction within a year, according to a newly released study mandated by the U.S. Food and Drug Administration.
13 hours ago
0
24
Preterm infant with drug-resistant seizures responds to antisense oligonucleotide treatment
Ludwig-Maximilians-Universität München-led researchers have induced a greater than 60% reduction in seizure frequency in a preterm infant with early-onset SCN2A developmental and epileptic encephalopathy (DEE). Seizures ...
Single-dose gel clears ear infections in animal study within 24 hours
Ear infections are a common and painful occurrence in infants and toddlers. Oral antibiotics are often prescribed for a week to treat the condition, but these drugs can trigger side effects that disrupt treatment, which can ...
May 5, 2025
0
68
Promising Parkinson's drug decoded
How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function—defective cell components are marked, disposed of and recycled. This includes ...
May 5, 2025
0
46
Drug resistance worsens UTI crisis in Malawi
A growing resistance to antibiotics is complicating the treatment of urinary tract infections (UTIs) in Malawi, with new research revealing that nearly half of women presenting with symptoms at a major referral hospital had ...
May 5, 2025
0
0
Scientists introduce new engineered drug candidate for Mycobacterium abscessus, a dangerous cousin of TB
In a classic example of scientific problem solving, scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) and colleagues have published a paper introducing a promising new drug candidate they engineered ...
May 2, 2025
0
23
Large-scale heart failure initiative boosts use of lifesaving medications
About 6.7 million adults in the U.S. are living with heart failure, and that number is expected to increase to more than 8 million by 2030.
May 2, 2025
0
0
EU pharmaceutical regulation reforms needed to drive innovation and investment, experts suggest
New research from Bayes Business School, in collaboration with biopharmaceuticals company Merck KGaA, suggests member states from the European Union (EU) must work more closely together, provide better incentives for the ...
May 2, 2025
0
0
Revealing the impact of tirzepatide treatment on muscle composition in type 2 diabetes
A recent analysis of the SURPASS-3 trial unravels the impact of treatment with the drug tirzepatide on muscle volume and fat infiltration in individuals with type 2 diabetes.
May 1, 2025
0
45
FDA-designated orphan drug could increase radiation efficacy in lung cancer
An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of radiation treatments in preclinical models, according to a study by UT Southwestern Medical Center ...
May 1, 2025
0
0
A generation at risk: Prenatal opioid exposure tied to hidden health problems
Exposure to opioids during pregnancy could be causing long-term, unknown health conditions for a generation of children, a University of Dundee expert has warned.
May 1, 2025
0
0
Study marks rise in psychotherapy outpatient visits and declines in medication use for mental health care
Psychotherapy assumed a larger role in outpatient mental health care while psychiatric medication without psychotherapy became less common, according to a study at Columbia University Mailman School of Public Health and Columbia ...
May 1, 2025
0
2
Kānuka extract shows promise in reducing organ transplant medication's side effects
Researchers have identified a compound in an extract from native kānuka that may have the potential to limit the adverse effects of rapamycin, a drug primarily used as an immune suppressant in kidney transplants.
May 1, 2025
0
1
Which medications are commonly prescribed for autistic people and why?
Autism is a neurodevelopmental condition. Someone may have social and communication differences, sensory issues and/or restricted, repetitive patterns of behavior or interests.
May 1, 2025
0
0
Semaglutide effectively treats liver disease in two thirds of patients, research finds
Results from the ESSENCE Phase III clinical trial published in the New England Journal of Medicine show treating patients with semaglutide can halt and even reverse liver disease.
Apr 30, 2025
0
210
National-level actions found to be effective at tackling antibiotic resistance
National-level policies can reduce the impact of antibiotic resistance across diverse countries, according to a study published in the open-access journal PLOS Global Public Health by Peter Søgaard Jørgensen from Stockholm ...
Apr 30, 2025
0
31
Old drug, new tricks: Why an anti-psychotic could help treat brain cancer
New research from SAHMRI and Flinders University has shed light on how the decades-old antipsychotic drug, trifluoperazine (TFP), works against glioblastoma (GBM), the most aggressive form of brain cancer.
Apr 30, 2025
0
1
Gabapentinoids unlikely to be directly linked to self-harm risk, study finds
Treatment with gabapentinoids—drugs such as gabapentin and pregabalin—is not directly associated with an increased risk of self-harm, finds a UK study published by The BMJ.
Apr 30, 2025
0
0
Broader antibiotic use could change the course of cholera outbreaks
Cholera kills thousands of people and infects hundreds of thousands every year—and cases have spiked in recent years, leaving governments with an urgent need to find the best ways to control outbreaks.
Apr 29, 2025
0
17
